Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium

被引:44
作者
Läer, S
Remmers, F
Scholz, H
Stein, B
Müller, FU
Neumann, J
机构
[1] Univ Munster, Inst Pharmakol & Toxikol, D-48149 Munster, Germany
[2] Univ Hamburg, Krankenhaus Eppendorf, Abt Allgemeine Pharmakol, D-20246 Hamburg, Germany
关键词
5-HT-receptors; inotropy; ketanserin; GR; 125487; SB; 203186;
D O I
10.1038/sj.bjp.0701702
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of 5-hydroxytryptamine (5-HT) in rat cardiac preparations were studied. 5-HT up to 10 mu M failed to affect contractility in papillary muscles. However, in electrically driven (1 Hz) left atria 5-HT exerted a positive inotropic effect that started at 1 mu M and attained its maximum at 10 mu M (312+/-50% of predrug value, n=8). 2 5-HT 10 mu M stimulated the content of inositol-1,4,5-trisphosphate but not of cyclic AMP in rat left atria. 3 Plasma and serum levels of 5-HT amounted to about 0.3 mu M and 15 mu M, respectively. 4 The selective 5-HT, receptor antagonists GR 125487 (10 nM and 1 mu M) and SB 203186 (1 mu M) did not attenuate the positive inotropic effect of 5-HT in rat left atria. In contrast, the 5-HT2 receptor antagonist ketanserin (5 nM, 50 nM, 1 mu M) resulted in a concentration-dependent diminution of the positive inotropic effect of 5-HT in rat left atria. 5 Reverse transcriptase polymerase chain reaction with specific primers detected mRNA of the 5-HT2A receptor in rat atria and ventricles, while expression of the 5-HT4 receptor was confined to atria. 6 It is suggested that the positive inotropic effect of 5-HT in electrically driven rat left atria is mediated by ketanserin-sensitive 5-HT2A receptors and not through 5-HT4 receptors.
引用
收藏
页码:1182 / 1188
页数:7
相关论文
共 43 条
  • [1] DISSOCIATION OF 5-HYDROXYTRYPTAMINE EFFECTS ON MYOCARDIAL-CONTRACTILITY AND CYCLIC-AMP ACCUMULATION
    BENFEY, BG
    COHEN, J
    KUNOS, G
    VERMESKU.I
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1974, 50 (04) : 581 - 585
  • [2] BOESS FG, 1994, NEUROPHARMACOLOGY, V3, P261
  • [3] BOHM M, 1984, J PHARMACOL EXP THER, V230, P483
  • [4] Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
    Booz, GW
    Baker, KM
    [J]. HYPERTENSION, 1996, 28 (04) : 635 - 640
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] EFFECTS OF CHRONIC TREATMENT WITH DEXFENFLURAMINE ON SEROTONIN IN RAT-BLOOD, BRAIN AND LUNG-TISSUE
    CELADA, P
    MARTIN, F
    ARTIGAS, F
    [J]. LIFE SCIENCES, 1994, 55 (15) : 1237 - 1243
  • [7] PHARMACOLOGICAL ANALYSIS OF THE CARDIAC EFFECTS OF 5-HT AND SOME 5-HT RECEPTOR AGONISTS IN THE PITHED RAT
    DABIRE, H
    CHAOUCHETEYARA, K
    CHERQUI, C
    FOURNIER, B
    SCHMITT, H
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (06) : 237 - 245
  • [8] DOCHERTY JR, 1988, N-S ARCH PHARMACOL, V337, P1
  • [9] DU YD, 1994, EUR J PHARMACOL, V259, P173
  • [10] CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE RAT STOMACH FUNDUS SEROTONIN RECEPTOR
    FOGUET, M
    HOYER, D
    PARDO, LA
    PAREKH, A
    KLUXEN, FW
    KALKMAN, HO
    STUHMER, W
    LUBBERT, H
    [J]. EMBO JOURNAL, 1992, 11 (09) : 3481 - 3487